Literature DB >> 23529951

High-resolution magic angle spinning 1H MRS in prostate cancer.

Emily A Decelle1, Leo L Cheng.   

Abstract

Prostate cancer (PCa) is the most frequently diagnosed malignancy in men worldwide, largely as a result of the increased use of the annual serum prostate-specific antigen (PSA) screening test for detection. PSA screening has saved lives, but it has also resulted in the overtreatment of many patients with PCa because of a limited ability to accurately localize and characterize PCa lesions through imaging. High-resolution magic angle spinning (HRMAS) (1)H MRS has proven to be a strong potential clinical tool for PCa diagnosis and prognosis. The HRMAS technique allows valuable metabolic information to be obtained from ex vivo intact tissue samples and also enables the performance of histopathology on the same tissue specimens. Studies have found that the quantification of individual metabolite levels and metabolite ratios, as well as metabolomic profiles, shows strong potential to improve accuracy in PCa detection, diagnosis and monitoring. Ex vivo HRMAS is also a valuable tool for the interpretation of in vivo results, including the localization of tumors, and thus has the potential to improve in vivo diagnostic tests used in the clinic. Here, we primarily review publications of HRMAS (1)H MRS and its use for the study of intact human prostate tissue.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRS; high-resolution magic angle spinning (HRMAS); intact tissue; prostate cancer

Mesh:

Substances:

Year:  2013        PMID: 23529951      PMCID: PMC3797175          DOI: 10.1002/nbm.2944

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  46 in total

1.  Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T.

Authors:  L L Cheng; C Wu; M R Smith; R G Gonzalez
Journal:  FEBS Lett       Date:  2001-04-06       Impact factor: 4.124

2.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra.

Authors:  P Hahn; I C Smith; L Leboldus; C Littman; R L Somorjai; T Bezabeh
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

3.  Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.

Authors:  R Dittrich; J Kurth; E A Decelle; E M DeFeo; M Taupitz; S Wu; C-L Wu; W S McDougal; L L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-31       Impact factor: 5.554

4.  Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.

Authors:  Mark G Swanson; Andrew S Zektzer; Z Laura Tabatabai; Jeffry Simko; Samson Jarso; Kayvan R Keshari; Lars Schmitt; Peter R Carroll; Katsuto Shinohara; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

5.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.

Authors:  L L Cheng; M J Ma; L Becerra; T Ptak; I Tracey; A Lackner; R G González
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy.

Authors:  Helena Bertilsson; Anders Angelsen; Trond Viset; Haakon Skogseth; May-Britt Tessem; Jostein Halgunset
Journal:  Prostate       Date:  2010-09-21       Impact factor: 4.104

7.  Semi-parametric time-domain quantification of HR-MAS data from prostate tissue.

Authors:  Helene Ratiney; Mark J Albers; Herald Rabeson; John Kurhanewicz
Journal:  NMR Biomed       Date:  2010-09-15       Impact factor: 4.044

8.  Classification of human tumours by high-resolution magnetic resonance spectroscopy.

Authors:  C E Mountford; J K Saunders; G L May; K T Holmes; P G Williams; R M Fox; M H Tattersall; J R Barr; P Russell; I C Smith
Journal:  Lancet       Date:  1986-03-22       Impact factor: 79.321

9.  Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.

Authors:  Friederike Teichert; Richard D Verschoyle; Peter Greaves; Richard E Edwards; Orla Teahan; Donald J L Jones; Ian D Wilson; Peter B Farmer; William P Steward; Timothy W Gant; Andreas J Gescher; Hector C Keun
Journal:  Prostate       Date:  2008-07-01       Impact factor: 4.104

10.  High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies.

Authors:  Jack J A van Asten; Vincent Cuijpers; Christina Hulsbergen-van de Kaa; Claudia Soede-Huijbregts; J Alfred Witjes; Albert Verhofstad; Arend Heerschap
Journal:  MAGMA       Date:  2008-11-25       Impact factor: 2.310

View more
  10 in total

Review 1.  NMR-based metabolomics studies of human prostate cancer tissue.

Authors:  Ana Rita Lima; Joana Pinto; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolomics       Date:  2018-06-18       Impact factor: 4.290

2.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

3.  Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D 1 H MRSI without water-signal suppression.

Authors:  Nassim Tayari; Alan J Wright; Arend Heerschap
Journal:  Magn Reson Med       Date:  2021-09-23       Impact factor: 3.737

4.  The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy.

Authors:  Monika Dezortova; Filip Jiru; Antonin Skoch; Vaclav Capek; Zuzana Ryznarova; Viktor Vik; Milan Hajek
Journal:  MAGMA       Date:  2016-08-13       Impact factor: 2.310

Review 5.  MRS-based Metabolomics in Cancer Research.

Authors:  Tedros Bezabeh; Omkar B Ijare; Alexander E Nikulin; Rajmund L Somorjai; Ian Cp Smith
Journal:  Magn Reson Insights       Date:  2014-02-13

6.  GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells.

Authors:  Ana Rita Lima; Ana Margarida Araújo; Joana Pinto; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolites       Date:  2018-03-19

7.  Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours.

Authors:  Christopher D Bennett; Sarah E Kohe; Simrandip K Gill; Nigel P Davies; Martin Wilson; Lisa C D Storer; Timothy Ritzmann; Simon M L Paine; Ian S Scott; Ina Nicklaus-Wollenteit; Daniel A Tennant; Richard G Grundy; Andrew C Peet
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

8.  Effectiveness of a muticomponent workout program integrated in an evidence based multimodal program in hyperfrail elderly patients: POWERAGING randomized clinical trial protocol.

Authors:  Manuel González-Sánchez; Antonio Ignacio Cuesta-Vargas; María Del Mar Rodríguez González; Elvira Díaz Caro; Germán Ortega Núñez; Alejandro Galán-Mercant; Juan José Bedoya Belmonte
Journal:  BMC Geriatr       Date:  2019-06-21       Impact factor: 3.921

Review 9.  Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer.

Authors:  R Ravikanth Reddy; Naranamangalam R Jagannathan
Journal:  Indian J Urol       Date:  2022-04-01

10.  Effectiveness of an individualized program of muscular strength and endurance with aerobic training for improving germ cell cancer-related fatigue in men undergoing chemotherapy: EFICATEST study protocol for a randomized controlled trial.

Authors:  Antonio Ignacio Cuesta-Vargas; Francisco Carabantes; Zaira Caracuel; Inmaculada Conejo; Emilio Alba
Journal:  Trials       Date:  2016-01-05       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.